top of page

The Verdict Is In: Marijuana Legalization Has Been A Success Story For States (Op-Ed)

  • Writer: Bob Marley
    Bob Marley
  • Mar 31, 2024
  • 3 min read

“After a century of failed policies and ‘canna-bigotry,’ the verdict is in. Legalization is a success, and the end of cannabis prohibition can’t come soon enough.”

By Paul Armentano, NORML

It’s been over a decade since Colorado and Washington became the first two states to legalize marijuana for adults. With the benefit of hindsight, it’s fair to ask: Has this policy been successful?

Absolutely. A policy of legalization, regulation, and education is preferable to a policy of criminalization, stigmatization, and incarceration.

Let’s be clear. Legalization didn’t create or normalize the marijuana market in the United States. The market was already here.

But under a policy of prohibition, this market flourished underground—and those involved in it remained largely unaccountable. They didn’t pay taxes, they didn’t check IDs, and they didn’t test the purity of their products. Disputes that arose in the illicit marketplace were not adjudicated in courts of law.

By contrast, under regulation, cannabis products in many states are now available from licensed manufacturers at retail stores.

Cannabis is cultivated, and products are manufactured, in accordance with good manufacturing practices. Products are lab tested and labeled accordingly. And sales are taxed, with revenues being reinvested in the community. Since 2014, retail sales of adult-use cannabis products have generated more than $15 billion in tax revenue.

Most importantly, millions of Americans—many of them young adults—are no longer being arrested for possessing a substance that is objectively safer than either tobacco or alcohol.

According to data compiled by the Federal Bureau of Investigation, the annual number of marijuana-related arrests in the United States fell from 750,000 in 2012 to 227,000 in 2022, the last year for which data is available.

In short, these state-level policy changes have resulted in countless Americans being spared criminal records—and the lost opportunities that accompany them—in the past decade.

And contrary to opponents’ fears, cannabis use by teens has risen in parallel with legalization.

According to data provided by the Centers for Disease Control and Prevention, the percentage of high schoolers who use marijuana actually  30 percent over the past decade. Compliance check data from California, Colorado, Nevada, and other legal marijuana states show that licensed marijuana retailers do not sell products to underage patrons.

Also contrary to some critics’ claims, legalization states have not experienced any spike in either psychosis or mental illnesses.

According to findings published last year in the , rates of psychosis-related health care claims are no higher in jurisdictions where cannabis is legal than in those where it’s not. Stanford University researchers similarly reported last year that residents of states where cannabis is legal exhibit no higher levels of psychosis than those in non-legal states.

Legalization is also successfully disrupting the illicit marketplace. According to a 2023 survey, 52 percent of consumers residing in legal states said that they primarily sourced their cannabis products from brick-and-mortar establishments. By contrast, only 6 percent of respondents said that they primarily purchased cannabis from a “dealer.”

Many consumers in non-legal states also reported that they frequently traveled to neighboring legal states to purchase cannabis products rather than buying from illicit dealers in their own state.

Twelve years into states’ marijuana legalization experiment, public support for making marijuana legal nationwide has never been higher. To date, 24 states have legalized the adult-use market.

None of these states have repealed their legalization laws. That’s because these policies are working largely as voters and politicians intended—and because they’re preferable to cannabis criminalization.

After a century of failed policies and “canna-bigotry,” the verdict is in. Legalization is a success, and the end of cannabis prohibition can’t come soon enough.

Paul Armentano is the Deputy Director for NORML, the National Organization for the Reform of Marijuana Laws.

This op-ed was first published by OtherWords.

Biden Touts Marijuana Scheduling Review And Pardons In New Proclamation For ‘Second Chance Month’

Photo courtesy of Max Pixel.

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page